v3.26.1
OTHER RECEIVABLE
 3 Months Ended
Mar. 31, 2026
OTHER RECEIVABLE  
OTHER RECEIVABLE

NOTE 6: OTHER RECEIVABLE

Other receivable mainly consists of grant income receivable. Qualifying grant income earned in advance of cash received from grants is recognized as other income and recorded as other receivable. The following table summarizes the Company’s other receivable balance as of March 31, 2026 and December 31, 2025, respectively:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

March 31,

  ​ ​ ​

December 31,

​

​

2026

​

2025

Grant income receivable:

 

​

  ​

 

​

  ​

CPRIT AML Grant

​

$

1,054,666

​

$

815,436

FDA Grant

​

 

2,903

​

 

3,678

SBIR AML Grant

​

 

116,504

​

 

162,897

Decoy Grant

​

 

73,328

​

 

59,501

SBIR NHL Grant

​

 

—

​

 

87,417

PANACEA Grant

​

 

73,478

​

 

190,052

Total grant income receivable

​

 

1,320,879

​

 

1,318,981

Interest receivable

​

 

43,218

​

 

50,419

Other

​

 

13,203

​

 

—

Total other receivable

​

$

1,377,300

​

$

1,369,400

​

Refer to Note 3 for details related to awarded grants and Note 10 for more information on grant income.